EGFR Protein, Human (Active, sf9, His-GST)

2 Cited Publications
Customer Review

Based on 2 publication(s) in Google Scholar

EGFR is a transmembrane glycoprotein. EGFR binds to ligands, triggering receptor dimerization, inducing intracellular TK domain autophosphorylation, activating downstream Ras/MAPK, PI3K/Akt and other signaling pathways, and regulating cell proliferation, survival, migration and angiogenesis. EGFR Protein, Human (sf9, His-GST) is a recombinant EGFR protein expressed by Sf9 insect cells with N-His, N-GST tags.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: Sf9 insect cells
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • References
  • Help & FAQs

Biological Activity

Description

EGFR is a transmembrane glycoprotein. EGFR binds to ligands, triggering receptor dimerization, inducing intracellular TK domain autophosphorylation, activating downstream Ras/MAPK, PI3K/Akt and other signaling pathways, and regulating cell proliferation, survival, migration and angiogenesis. EGFR Protein, Human (sf9, His-GST) is a recombinant EGFR protein expressed by Sf9 insect cells with N-His, N-GST tags.

Background

EGFR belongs to the epidermal growth factor receptor family[1][2][3][4][5]. EGFR is a transmembrane glycoprotein. EGFR has an extracellular domain of 621 amino acids, a single transmembrane domain of 23 amino acids, and an enzymatically active intracellular domain of 542 amino acids[6]. EGFR binds to its ligand, triggers receptor dimerization, induces autophosphorylation of the intracellular TK domain, activates downstream Ras/MAPK, PI3K/Akt and other signaling pathways, and regulates cell proliferation, survival, migration and angiogenesis[1][3][4][5]. EGFR is expressed in a variety of normal epithelial tissues and tumor tissues, such as breast, lung, stomach, colon, head and neck, and its abnormal expression is associated with the malignant progression of tumors[1][2][3][4][5].

Verified Bioactivity

The specific activity was determined to be ≥4 nmol/min/mg using Poly(Glu:Tyr) 4:1 as substrate.

Assay Procedure

Materials
Assay buffer A(5X): 200 mM Tris-HCl, pH 7.5, 100 mM MgCl2 and 0.5 mg/mL BSA
Buffer 1(2X): 1 mL assay buffer A, 2.5 μL DTT (0.1 M), 10 μL MnCl2 (1 M) and 1.5 mL of dH20
Buffer 2 (1X): 1 mL assay buffer 1, and 1 mL dH2O
Test protein: EGFR Protein, Human (Active, sf9, His-GST) (HY-P72987)
Substrate: Poly (Glu : Tyr) 4:1
ADP-Glo kit

Procedure
1. Thaw the ADP-GloTM Reagents at ambient temperature. Then prepare Kinase Detection Reagent by mixing Kinase assay buffer with the Lyophilized Kinase Detection Substrate.
2. Thaw the components of enzyme system, ADP and ATP on ice.
3. Prepare 1 mL of 250 μM ATP Sssay Solution by adding 25 μL ATP solution (10 mM) to 500 μL of 2X buffer and 475 μL of dH2O.
4. In a white 96 well plate, add the following reaction components bringing the initial reaction volume up to 20 μL:
a. 10 μL of diluted active enzyme.
b. 5 μL of 1mg/mL stock solution of substrate (final Conc.: 0.2 mg/mL).
5. Set up the blank control as outlined in step (4), excluding the addition of the substrate. Replace the substrate with an equal volume of dH2O.
6. Initiate the reactions by the addition of 5 μL of 250 μM ATP assay solution thereby bringing the final volume up to 25 μL. Shake the plate and incubate the reaction mixture at R.T. for 60 minutes.

Components Volume (μL) Blank Control (μL)
Active enzyme 10 10
Substrate stock solution (1 mg/mL) 5 5 μL dH2O
2X buffer 5 5
ATP assay solution (250 μM) 5 5
7. As the kinase reaction, set up an ATP to ADP conversion curve at 50 μM ATP/ADP range as described in the ADP-GloTM Kinase Assay technical Manual.
8. Terminate the reaction and deplete the remaining ATP by adding 25 μL of ADP- GloTM Reagent. Shake the 96 well plate and then incubate the reaction mixture for another 40 minutes at R.T.
9. Add 50 μL of the Kinase Detection Reagent, shake the plate and then incubate the reaction mixture for another 30 minutes at R.T.
10. Read the 96-well reaction plate using Microplate Luminomet.
11. Calculate specific activity:

     Specific Activity (nmol/min/μg) =

Phosphate released* (nmol)
Reaction time (min) × amount of enzyme (μg)

*Derived from the phosphate standard curve and adjusted for Control.

Technical Parameters

  • Species Human
  • Source Sf9 insect cells
  • Tag N-GST;N-10*His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • 10*His-GST
    • EGFR (M668-A1210)
      Accession # P00533-1
    • C-term
  • Protein Length

    Cytoplasmic Domain

  • Synonyms

    EGFR; Epidermal Growth Factor Receptor Variant EX12_14del; Prev. ERBB; Cell Proliferation-Inducing Protein 61; ERBB1; Cell Growth Inhibiting Protein 40; ERRP; Receptor Protein-Tyrosine Kinase; Receptor Tyrosine-Protein Kinase ErbB-1; Alternative Protein E

  • AA Sequence

    MRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA

  • Predicted Molecular Mass

    89.1 kDa

  • Molecular Weight

    89.1 kDa

  • Glycosylation

    Yes

  • Purity

    ≥ 75%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution.

Formulation

1.Supplied as a 0.22 μm filtered solution of 20 mM Tris, 300 mM NaCl, 10% glycerol, 0.02% Triton X-100, 0.4 mM β-Me, 0.5 mM GSH, 0.5 mM PMSF, pH 7.5.
2.Supplied as a 0.22 μm filtered solution of 20 mM Tris, 300 mM NaCl, 10% glycerol, pH 7.5, 0.02% Triton X-100, 0.4 mM β-mercaptoethanol, 0.5 mM PMSF, 2 mM GSH.
Please refer to the lot-specific COA for specific buffer information.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

Please use rapid thawing with running water to thaw the protein.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

References

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00